Shamburg News · 8-K filed Oct 15, 2026, 10:27 AM EDT

Corbus Pharmaceuticals Updates Corporate Presentation in Regulation FD Disclosure

CRBP · Corbus Pharmaceuticals Holdings, Inc.

  • Reg FD disclosure
  • Other event
  • Materiality: low

Corbus Pharmaceuticals Holdings, Inc. updated the investor presentation management uses to describe its business. The updated presentation is furnished as Exhibit 99.1 and is not deemed filed under Section 18 of the Exchange Act. The filing reports no financial results, dividends, splits, or officer changes.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001193125-26-422437.

Written from the filing by Shamburg Markets. Figures are as reported by the company.